Morphic Holding, Inc. - stock earnings
MORF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -40.7 million USD | -60.2 million USD |
| 2023Q3 | -36.2 million USD | ? USD |
| 2023Q2 | -39.0 million USD | 60.2 million USD |
| 2023Q1 | -36.1 million USD | 521000 USD |
| 2022Q4 | -24.4 million USD | 6.1 million USD |
| 2022Q3 | -30.0 million USD | 2.1 million USD |
| 2022Q2 | 26.8 million USD | 60.2 million USD |
| 2022Q1 | -31.3 million USD | 2.4 million USD |
| 2021Q4 | -21.4 million USD | 9.6 million USD |
| 2021Q3 | -25.0 million USD | 3.1 million USD |
| 2021Q2 | -27.8 million USD | 3.8 million USD |
| 2021Q1 | -21.3 million USD | 3.3 million USD |
| 2020Q4 | -17.7 million USD | 5.9 million USD |
| 2020Q3 | 5.4 million USD | 25.8 million USD |
| 2020Q2 | -15.9 million USD | 7.7 million USD |
| 2020Q1 | -16.7 million USD | 5.6 million USD |
| 2019Q4 | -19.8 million USD | -334000 USD |
| 2019Q3 | -8.9 million USD | 5.7 million USD |
| 2019Q2 | -9.4 million USD | 5.6 million USD |
| 2019Q1 | -5.2 million USD | 6.1 million USD |
| 2018Q4 | -5.3 million USD | 3.4 million USD |
| 2018Q3 | -7.1 million USD | ? USD |
| 2018Q2 | -6.2 million USD | ? USD |
| 2018Q1 | -5.2 million USD | ? USD |
MORF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -152.1 million USD | 521000 USD |
| 2022 | -59.0 million USD | 70.8 million USD |
| 2021 | -94.2 million USD | 19.8 million USD |
| 2020 | -45.0 million USD | 44.9 million USD |
| 2019 | -43.3 million USD | 17.0 million USD |
| 2018 | -23.8 million USD | 3.4 million USD |
| 2017 | -16.9 million USD | ? USD |
MORF
Price: $28.07
52 week price:
Earnings Per Share: -3.59 USD
P/E Ratio: -10.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 148800
Market Capitalization: 1.5 billion